## 



## 

## 



## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 




## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

|||`Unrestricted`|`Total`|`Total`|
|---|---|---|---|---|
|||`funds`|`funds`|`funds`|
|||`2025`|`2025`|`2024`|
|||`£`|`£`|`£`|
|`Incomefrom:`|||||
|`Donationsandgifts`||`450,000`|`450,000`|`375,000`|
|`Totalincome`||`450,000`|`450,000`|`375,000`|
|`Expenditureon:`|||||
|`Charitableactivities`|`4`|`537,104`|`537,104`|`352,462`|
|`Totalexpenditure`||`537,104`|`537,104`|`352,462`|
|`Netmovementinfunds`||`(87,104)`|`(87,104)`|`22,538`|
|`Reconciliationoffunds:`|||||
|`Totalfundsbroughtforward`||`134,035`|`134,035`|`111,497`|
|`Netmovementinfunds`||`(87,104)`|`(87,104)`|`22,538`|
|`Totalfundscarriedforward`||`46,931`|`46,931`|`134,035`|





## 

||||`2025`||`2024`|
|---|---|---|---|---|---|
||`Note`||`£`||`£`|
|`Fixedassets`||||||
|`Tangibleassets`|`7`||`72,558`||`48813`|
|`Currentassets`||||||
|`Debtors`|`8`|`418`||`-`||
|`Cashatbankandinhand`||`5,031`||`89,103`||
|||`5,449`||`89,103`||
|`Currentliabilities`||||||
|`Creditors:amountsfallingduewithinone`||||||
|`year`|`9`|`(31,076)`||`(3,881)`||
|`Netcurrent(liabilities)/ assets`|||`(25,627)`||`85,222`|
|`Totalnetassets`|||`46,931`||`134,035`|
|`Charityfunds`||||||
|`Unrestrictedfunds`|`10`||`46,931`||`134,035`|
|`Totalfunds`|||`46,931`||`134,035`|






## 

## 

||`Note`|`2025`<br>`£`|`2024`<br>`£`|
|---|---|---|---|
|`Cashflowsfromoperatingactivities`||||
|`Netcash(usedin)/fromoperatingactivities`|`12`|`(55,549)`|`34,162`|
|`Cashflowsfrominvestingactivities`||||
|`Purchaseoftangiblefixedassets`||`(28,523)`|`:`|
|`Netcash(usedin)/providedbyinvestingactivities`||`(28,523)`|`-`|
|`Changeincashandcashequivalentsintheyear`||`(84,072)`|`34,162`|
|`Cashandcashequivalentsatthebeginningoftheyear`||`89,103`|`54,941`|
|`Cashandcashequivalentsattheendoftheyear`|`13`|`5,031`|`89,103`|
|`Thenotesonpages12to19formpartofthesefinancialstatements`||||





## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

||`Unrestricted`|||
|---|---|---|---|
||`funds`|`Total`|`Total`|
||`2025`|`2025`|`2024`|
||`£`|`£`|`£`|
|`Grantspayable(seenote5)`|`513,364`|`513,364`|`345,442`|
|`Bankcharges`|`810`|`810`|`424`|
|`Motorexpenses`|`1,230`|`1,230`|`860`|
|`Legalcosts`|`13,000`|`13,000`|`500`|
|`Auditfee`|`3,922`|`3,922`|`3,429`|
|`Depreciationcosts`|`4,778`|`4,778`|`1,807`|
|`Total2025`|`537,104`|`537,104`|`352,462`|
|`Total2024`|`352,462`|`352,462`||





## 

## 

## 

||`2025`|`2024`|
|---|---|---|
||`£`|`£`|
|`Grantstoinstitutions`|||
|`StBasils`|`10,000`|`10,000`|
|`TheGet-A-HeadCharitableTrust`|`50,000`|`50,000`|
|`IrishWheelchairAssociation`|`42,715`|`22,156`|
|`JerichoRoadProject`|`6,000`|`10,000`|
|`Zoe'sPlaceBabyHospice`|`5,000`|`-`|
|`AirAmbulance`|`10,000`|`-`|
|`Crohns& ColitisUK`|`10,000`|`-`|
|`Refuge`|`10,000`|`-`|
|`TargetOvarianCancer`|`5,000`|`-`|
|`ChildrenwithCancer`|`5,000`|`-`|
|`MelanomaUKLtd`|`5,000`|`-`|
||`158,715`|`92,156`|
|`Grantstoindividuals`|||
|`Medical`|`342,649`|`241,286`|
|`Hardshiprelief`|`12,000`|`12,000`|
||`354,649`|`253,286`|
|`Totalgrantspayable`|`513,364`|`345,442`|



## 



## 

## 

## 

||`Freehold`|`Motor`||
|---|---|---|---|
||`property`|`vehicles`|`Total`|
||`£`|`£`|`£`|
|`Costorvaluation`||||
|`At1 May2024`|`90,374`|`20,811`|`111,185`|
|`Additions`|`-`|`28,523`|`28,523`|
|`At30April2025`|`90,374`|`49,334`|`139,708`|
|`Depreciation`||||
|`At1 May2024`|`41,561`|`20,811`|`62,372`|
|`Chargefortheyear`|`1,807`|`2,971`|`4,778`|
|`At30April2025`|`43,368`|`23,782`|`67,150`|
|`Netbookvalue`||||
|`At30April2025`|`47,006`|`25,552`|`72,558`|
|`At30April2024`|`48,813`|`-`|`48,813`|
|`Debtors`||||
|||`2025`|`2024`|
|||`£`|`£`|
|`Prepaymentsandaccruedincome`||`418`|`-`|
|`Creditors:Amountsfallingduewithinoneyear`||||
|||`2025`|`2024`|
|||`£`|`£`|
|`Tradecreditors`||`1,810`|`-`|
|`Othertaxationandsocialsecurity`||`339`|`452`|
|`Accrualsanddeferredincome`||`28,927`|`3,429`|
|||`31,076`|`3,881`|





## 

## 

## 

## 

|||||`Balanceat`|
|---|---|---|---|---|
||`Balanceat1 `|||`30April`|
||`May2024`|`Income`|`Expenditure`|`2025`|
||`£`|`£`|`£`|`£`|
|`Unrestrictedfunds`|||||
|`DesignatedFunds`|`48,813`|`-`|`(1,807)`|`47,006`|
|`GeneralFunds`|`85,222`|`450,000`|`(535,297)`|`(75)`|
|`TotalUnrestrictedfunds`|`134,035`|`450,000`|`(537,104)`|`46,931`|
|`Statementoffunds- prioryear`|||||
||`Balanceat`|||`Balanceat`|
||`1May2023`|`Income`|`Expenditure`|`30April2024`|
||`£`|`£`|`£`|`£`|
|`Unrestrictedfunds`|||||
|`DesignatedFunds`|`50,620`|`-`|`(1,807)`|`48813`|
|`GeneralFunds`|`60,877`|`375,000`|`(350,655)`|`85,222`|
|`TotalUnrestrictedfunds`|`111,497`|`375,000`|`(352,462)`|`134,035`|





## 

## 

## 

## 

|||||`Unrestricted`|`Total`|
|---|---|---|---|---|---|
|||||`funds`|`funds`|
|||||`2025`|`2025`|
|||||`£`|`£`|
|`Tangible`|`fixed`|`assets`||`72,558`|`72,558`|
|`Current`|`assets`|||`5,449`|`5,449`|
|`Creditors`|`due`|`within`|`oneyear`|`(31,076)`|`(31,076)`|
|`Total`||||`46,931`|`46,931`|



## 

|||||`Unrestricted`|`Total`|
|---|---|---|---|---|---|
|||||`funds`|`funds`|
|||||`2024`|`2024`|
|||||`£`|`£`|
|`Tangible`|`fixed`|`assets`||`48,813`|`48,813`|
|`Current`|`assets`|||`89,103`|`89,103`|
|`Creditors`|`due`|`within`|`oneyear`|`(3,881)`|`(3,881)`|
|`Total`||||`134,035`|`134,035`|



## 

||`2025`|`2024`|
|---|---|---|
||`£`|`£`|
|`Net(expenditure)/incomefortheyear(asperStatementofFinancial`|||
|`Activities)`|`(87,104)`|`22,538`|
|`Adjustmentsfor:`|||
|`Depreciationcharges`|`4,778`|`1,807`|
|`(Increase)/decreaseindebtors`|`(418)`|`9,285`|
|`Increaseincreditors`|`27,195`|`532`|
|`Netcash(usedin)/providedbyoperatingactivities`|`(55,549)`|`34,162`|





## 


## 


## 



##